These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 22339748

  • 1. Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis.
    Chen YH, Yang XM, Li SS, Wang YH, He JJ, Yang YD, Wang S, Liu JJ, Zhang XL.
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):66-74. PubMed ID: 22339748
    [Abstract] [Full Text] [Related]

  • 2. [The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
    Fülöp M, Kásler M, Remenár E, Lengyel Z, Borbély K.
    Magy Onkol; 2012 May; 56(2):84-92. PubMed ID: 22629545
    [Abstract] [Full Text] [Related]

  • 3. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G, Brouwer J, de Bree R, Pruim J, van der Laan BF, Vaalburg W, Hoekstra OS, Comans EF, Vissink A, Leemans CR, Roodenburg JL.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [Abstract] [Full Text] [Related]

  • 4. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
    Wartski M, Le Stanc E, Gontier E, Vilain D, Banal A, Tainturier C, Pecking AP, Alberini JL.
    Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
    [Abstract] [Full Text] [Related]

  • 5. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K, Luo XM, Zhou SH, Liu JH, Yan SX, Lu ZJ, Yang SY, Lin LL, Dong MJ.
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [Abstract] [Full Text] [Related]

  • 6. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
    Tamam MO, Mulazimoglu M, Guveli TK, Tamam C, Eker O, Ozpacaci T.
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y, Kubota K, Katayama T, Toriihara A, Shibuya H.
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [Abstract] [Full Text] [Related]

  • 8. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G.
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S.
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [Abstract] [Full Text] [Related]

  • 10. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
    Yapar Z, Kibar M, Yapar AF, Paydas S, Reyhan M, Kara O, Buyukdereli G, Aydin M, Kelle AP, Unal I, Disel U, Yavuz S, Sahin B, Erkisi M.
    Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921
    [Abstract] [Full Text] [Related]

  • 11. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
    Freudenberg LS, Fischer M, Antoch G, Jentzen W, Gutzeit A, Rosenbaum SJ, Bockisch A, Egelhof T.
    Med Princ Pract; 2005 Jan; 14(3):155-60. PubMed ID: 15863988
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO, Halpenny D, Johnston C, Sheehy N, Keogan M.
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [Abstract] [Full Text] [Related]

  • 13. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
    Nakajo M, Nakajo M, Jinguji M, Tani A, Kajiya Y, Tanabe H, Fukukura Y, Nakabeppu Y, Koriyama C.
    Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
    [Abstract] [Full Text] [Related]

  • 15. Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.
    Nassenstein K, Veit-Haibach P, Stergar H, Gutzeit A, Freudenberg L, Kuehl H, Fischer M, Barkhausen J, Bockisch A, Antoch G.
    Acta Radiol; 2007 Dec; 48(10):1101-8. PubMed ID: 17963088
    [Abstract] [Full Text] [Related]

  • 16. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR, Kim JS, Roh JL, Lee JH, Baek JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [Abstract] [Full Text] [Related]

  • 17. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
    Paul SA, Stoeckli SJ, von Schulthess GK, Goerres GW.
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):189-95. PubMed ID: 17177026
    [Abstract] [Full Text] [Related]

  • 18. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K, Hay JH, Wilson DC.
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
    [Abstract] [Full Text] [Related]

  • 19. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
    Park JW, Jo MK, Lee HM.
    BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
    [Abstract] [Full Text] [Related]

  • 20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.